Home
Archives
Jerusalem Center Homepage
View the current issue
Jerusalem Center Videos
Additional Resources
Top Commentators:
- Elliott Abrams
- Fouad Ajami
- Shlomo Avineri
- Benny Avni
- Alan Dershowitz
- Jackson Diehl
- Dore Gold
- Daniel Gordis
- Tom Gross
- Jonathan Halevy
- David Ignatius
- Pinchas Inbari
- Jeff Jacoby
- Efraim Karsh
- Mordechai Kedar
- Charles Krauthammer
- Emily Landau
- David Makovsky
- Aaron David Miller
- Benny Morris
- Jacques Neriah
- Marty Peretz
- Melanie Phillips
- Daniel Pipes
- Harold Rhode
- Gary Rosenblatt
- Jennifer Rubin
- David Schenkar
- Shimon Shapira
- Jonathan Spyer
- Gerald Steinberg
- Bret Stephens
- Amir Taheri
- Josh Teitelbaum
- Khaled Abu Toameh
- Jonathan Tobin
- Michael Totten
- Michael Young
- Mort Zuckerman
Think Tanks:
- American Enterprise Institute
- Brookings Institution
- Center for Security Policy
- Council on Foreign Relations
- Heritage Foundation
- Hudson Institute
- Institute for Contemporary Affairs
- Institute for Counter-Terrorism
- Institute for Global Jewish Affairs
- Institute for National Security Studies
- Institute for Science and Intl. Security
- Intelligence and Terrorism Information Center
- Investigative Project
- Jerusalem Center for Public Affairs
- RAND Corporation
- Saban Center for Middle East Policy
- Shalem Center
- Washington Institute for Near East Policy
Media:
- CAMERA
- Daily Alert
- Jewish Political Studies Review
- MEMRI
- NGO Monitor
- Palestinian Media Watch
- The Israel Project
- YouTube
Government:
Back
(Jerusalem Post) Maayan Jaffe-Hoffman - 77% of patients suffering from stage IV metastatic pancreatic cancer and treated with a protocol developed by Israeli biopharmaceutical company BioLineRx were able to get their disease under control, according to results of an ongoing study. 2019-12-20 00:00:00Full Article
Israeli Pancreatic Cancer Treatment Could Extend Lives of 3/4 of Patients
(Jerusalem Post) Maayan Jaffe-Hoffman - 77% of patients suffering from stage IV metastatic pancreatic cancer and treated with a protocol developed by Israeli biopharmaceutical company BioLineRx were able to get their disease under control, according to results of an ongoing study. 2019-12-20 00:00:00Full Article
Search Daily Alert
|
Search:
|